Citation Impact

Citing Papers

Antiemetics: American Society of Clinical Oncology Clinical Practice Guideline Update
2011 Standout
Colorectal cancer statistics, 2020
2020 Standout
Cancer statistics, 2022
2022 Standout
Ensuring Quality Cancer Care
1999
Cancer statistics, 2023
2023 Standout
Cancer statistics, 2020
2020 Standout
Cancer statistics, 2024
2024 Standout
Cancer Statistics, 2021
2021 Standout
Survival Effect of Maximal Cytoreductive Surgery for Advanced Ovarian Carcinoma During the Platinum Era: A Meta-Analysis
2002 Standout
Geographical, racial and socio-economic variation in life expectancy in the US and their impact on cancer relative survival
2018
Cumulative Incidence of False-Positive Results in Repeated, Multimodal Cancer Screening
2009
Testicular Germ-Cell Cancer
1997 Standout
Hepatocellular carcinoma
2018 Standout
Chemotherapy for small cell lung cancer
2003
Global Cancer Statistics, 2002
2005 Standout
Prevalence of Prostate Cancer among Men with a Prostate-Specific Antigen Level ≤4.0 ng per Milliliter
2004 Standout
Paraneoplastic Syndromes Involving the Nervous System
2003 Standout
Neurologic disorders in patients with small cell lung cancer
1987
Dose calculation of anticancer drugs: a review of the current practice and introduction of an alternative.
1996 Standout
Race and Colorectal Cancer Disparities: Health-Care Utilization vs Different Cancer Susceptibilities
2010
Dissemination and growth of cancer cells in metastatic sites
2002 Standout
Escalating drug delivery in cancer chemotherapy: A review of concepts and practice —Part 2
1993
The biology and function of fibroblasts in cancer
2016 Standout
Hepatocellular carcinoma
2012 Standout
Legumes and soybeans: overview of their nutritional profiles and health effects
1999 Standout
NCI-navy medical oncology branch cell line data base
1996
Surgeon Volume and Operative Mortality in the United States
2003 Standout
Nutritional support of the hospitalized patient
1997
Second Cancers Among 40 576 Testicular Cancer Patients: Focus on Long-term Survivors
2005 Standout
Estimating the need for radiotherapy for lung cancer: an evidence-based, epidemiologic approach
2001
Multimodal biomedical AI
2022 Standout
Genome-wide polygenic scores for common diseases identify individuals with risk equivalent to monogenic mutations
2018 Standout
Chemotherapy-Induced Nausea and Vomiting
2008 Standout
AGA technical review on parenteral nutrition
2001
Publication bias in clinical research
1991 Standout
Principles of Cancer Screening: Lessons From History and Study Design Issues
2010
Chemotherapy as treatment of primary and recurrent small cell lung cancer
2001
Parenteral Nutrition in Cancer Patients Receiving Chemotherapy: Effects on Toxicity and Nutritional Status
1993
Mitochondrial Membrane Permeabilization in Cell Death
2007 Standout
Randomized, Controlled Trials, Observational Studies, and the Hierarchy of Research Designs
2000 Standout
The Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial of the National Cancer Institute: History, organization, and status
2000
Double-Cycle, High-Dose Ifosfamide, Carboplatin, and Etoposide Followed by Peripheral Blood Stem-Cell Transplantation for Small Cell Lung Cancer
2005
Microtubules as a target for anticancer drugs
2004 Standout
Cisplatin in cancer therapy: Molecular mechanisms of action
2014 Standout
Impact of Informing Overweight Individuals about the Role of Genetics in Obesity: An Online Experimental Study
2013 Standout
Early versus Late Parenteral Nutrition in Critically Ill Adults
2011 Standout
Dietary Fat and Prostate Cancer: Current Status
1999
Baseline Characteristics of Participants in the Randomized National Lung Screening Trial
2010
Nutritional risk screening (NRS 2002): a new method based on an analysis of controlled clinical trials
2003 Standout
Small-cell lung cancer
2005
Small Cell Lung Cancer
2008
Guidelines for the Prevention of Intravascular Catheter-related Infections
2011 Standout
Modulation of tumor cell gene expression and phenotype by the organspecific metastatic environment
1995
Non-Small Cell Lung Cancer: Epidemiology, Risk Factors, Treatment, and Survivorship
2008 Standout
International trends and patterns of prostate cancer incidence and mortality
2000
The NCI60 human tumour cell line anticancer drug screen
2006 Standout
Lung Cancer Risk Prediction: Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial Models and Validation
2011
Relation between literacy, race, and stage of presentation among low-income patients with prostate cancer.
1998
Global cancer statistics in the year 2000
2001 Standout
Silicosis
2012 Standout
A randomized study of oral nutritional support versus ad lib nutritional intake during chemotherapy for advanced colorectal and non-small-cell lung cancer.
1987
Biochemical Modulation of Cisplatin Mechanisms of Action:  Enhancement of Antitumor Activity and Circumvention of Drug Resistance
2003 Standout
Screening for Prostate Cancer: U.S. Preventive Services Task Force Recommendation Statement
2012 Standout
Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): Explanation and Elaboration
2015 Standout
Screening for Lung Cancer: U.S. Preventive Services Task Force Recommendation Statement
2013 Standout
Aggressiveness of Cancer Care Near the End of Life: Is It a Quality-of-Care Issue?
2008 Standout
Colorectal cancer statistics, 2017
2017 Standout
Invited Review: Nutrition Support in Patients With Cancer: What Do the Data Really Show?
1994
The role of radiotherapy in cancer treatment
2005 Standout
Cancer treatment and survivorship statistics, 2016
2016 Standout
Comparison of Sociodemographic and Health-Related Characteristics of UK Biobank Participants With Those of the General Population
2017 Standout
The PPARs:  From Orphan Receptors to Drug Discovery
2000 Standout
Proposal for classifying the acute emetogenicity of cancer chemotherapy.
1997 Standout
Cancer treatment and survivorship statistics, 2019
2019 Standout
Discussion
1999
Non-Small Cell Lung Cancer: Epidemiology, Risk Factors, Treatment, and Survivorship
2008 Standout
Cumulative Incidence of False-Positive Test Results in Lung Cancer Screening
2010
Phytoestrogens and prostate cancer: possible preventive role
1997
Modulation of tumor cell response to chemotherapy by the organ environment
1994
15-Year Followup of a Population Based Prostate Cancer Screening Study
2009
Hospital and Physician Volume or Specialization and Outcomes in Cancer Treatment: Importance in Quality of Cancer Care
2000
The Oral Neurokinin-1 Antagonist Aprepitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting: A Multinational, Randomized, Double-Blind, Placebo-Controlled Trial in Patients Receiving High-Dose Cisplatin—The Aprepitant Protocol 052 Study Group
2003 Standout
Long-Term Disease-Specific Functioning Among Prostate Cancer Survivors and Noncancer Controls in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial
2012
Total parenteral nutrition and cancer clinical trials
1986

Works of B S Kramer being referenced

Prospective randomized comparison of high-dose and standard-dose etoposide and cisplatin chemotherapy in patients with extensive-stage small-cell lung cancer.
1994
Prostate cancer screening: current issues
1996
Evidence of a Healthy Volunteer Effect in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial
2007
After a treatment breakthrough: a comparison of trial and population-based data for advanced testicular cancer.
1994
Chemosensitivity Patterns and Expression of Human Multidrug Resistance-Associated MDR1 Gene by Human Gastric and Colorectal Carcinoma Cell Lines
1990
The potential for hormonal prevention trials
1994
Effect of adjuvant central iv hyperalimentation on the survival and response to treatment of patients with small cell lung cancer: a randomized trial.
1985
Phase II evaluation of mitoxantrone in patients with bronchogenic carcinoma: a Southeastern Cancer Study Group trial.
1984
Effects of intravenous hyperalimentation during treatment in patients with small-cell lung cancer.
1985
Rankless by CCL
2026